NCT03635931

Brief Summary

The aim of this study was to evaluate the efficacy of concentrated growth factor (CGF) in applied in the regenerative treatment of multiple adjacent papillary black triangles (MAPBT) occured as a result of soft tissue loss. Interdental papillary regeneration was evaluated with the change in the area of interproximal spaces calculated on each of the intraorally scanned images obtained with digital impressions of the interproximal space with irregular borders.This controlled, examiner-blinded, clinical study included of 40 patients with 120 open embrasures which resulted from papillary loss in adjacent teeth in the anterior maxillary esthetic zone resulting in black triangles (BTs). Then patients were randomly assigned to receive surgical regenerative periodontal treatment(test) or periodontal care(control)The test group was formed of 20 patients with 60 adjacent papillary defects . A control group was formed of 20 patients with 60 adjacent papillary defects.. A total of 480 images obtained with the digital impressions . Evaluations of the test group were made preoperatively and at 3, 6 and 12 months postoperatively. For the control group, oral hygiene instruction was provided. Control group is evaluated by the same procedure with test group but the surgical part is not performed. Lost interdental papillary area (PA)were calculated. In the test group, the percentage of papillary filling, the presence of keratinized gingiva, the thickness of papillary gingiva, blood thrombocyte count and mean platelet volume values(MPV) were recorded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 30, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2018

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 12, 2018

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

August 13, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 17, 2018

Completed
Last Updated

July 30, 2019

Status Verified

July 1, 2019

Enrollment Period

1 year

First QC Date

August 13, 2018

Last Update Submit

July 29, 2019

Conditions

Keywords

CGFlost interdental papilla

Outcome Measures

Primary Outcomes (1)

  • change in the percentage of papillary fill(PF)

    The percentage of PF was also calculated as (\[ Lost Papillary area(PA) preoperation - PA postoperation\] / PA preoperation) x 100%.

    Change from 3 months percentage of papillary fill at 6 months

Study Arms (2)

Concentrated Growth Factor

ACTIVE COMPARATOR

plaque control, scaling and root planing if required, surgical application of CGF

Procedure: Concentrated Growth Factor

Control Group

NO INTERVENTION

plaque control, scaling and root planing if required

Interventions

surgical treatment with CGF for papilla regeneration

Concentrated Growth Factor

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Clinical diagnosis of interdental papillary losses in the maxillary anterior teeth, between the adjacent central teeth, the central and lateral teeth and the lateral and canine teeth
  • The presence of a contact point in the maxillary anterior teeth
  • optimal facial keratinized gingiva/ keratinized gingiva must be more than 2mm

You may not qualify if:

  • pregnancy or
  • breast-feeding,
  • palatal and gingival recession,
  • attachment loss,
  • high labial frenulum.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University Faculty of Dentistry Department of Periodontology

Ankara, Çankaya, 06510, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Calcinosis

Condition Hierarchy (Ancestors)

Calcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • zeynep Turgut Çankaya, PhD,Dr

    Gazi University, Faculty of Dentistry,Department of Periodontology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The test and control group was formed of patients with adjacent papillary defects In test group, elective minimally invasive surgery for papillary regeneration with CGF was performed. A control group was formed of patients with adjacent papillary defects who were not included to have surgical treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 13, 2018

First Posted

August 17, 2018

Study Start

July 30, 2017

Primary Completion

July 30, 2018

Study Completion

August 12, 2018

Last Updated

July 30, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations